Reuters logo
BRIEF-Astrazeneca says Benralizumab receives Positive EU CHMP opinion
2017年11月10日 / 中午11点44分 / 11 天前

BRIEF-Astrazeneca says Benralizumab receives Positive EU CHMP opinion

Nov 10 (Reuters) - ASTRAZENECA PLC:

* BENRALIZUMAB POSITIVE CHMP IN EOSINOPHILIC ASTHMA

* ‍ANNOUNCED THAT CHMP OF EUROPEAN MEDICINES AGENCY HAS ADOPTED POSITIVE OPINION, RECOMMENDING MARKETING AUTHORISATION OF BENRALIZUMAB​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below